IL283194B2 - C10-alkylene substituted 13-membered macrolides and uses thereof - Google Patents

C10-alkylene substituted 13-membered macrolides and uses thereof

Info

Publication number
IL283194B2
IL283194B2 IL283194A IL28319421A IL283194B2 IL 283194 B2 IL283194 B2 IL 283194B2 IL 283194 A IL283194 A IL 283194A IL 28319421 A IL28319421 A IL 28319421A IL 283194 B2 IL283194 B2 IL 283194B2
Authority
IL
Israel
Prior art keywords
optionally substituted
compound
group
alkyl
alkylene
Prior art date
Application number
IL283194A
Other languages
English (en)
Hebrew (he)
Other versions
IL283194B1 (en
IL283194A (en
Original Assignee
Zikani Therapeutics Inc
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=68916562&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL283194(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zikani Therapeutics Inc, Harvard College filed Critical Zikani Therapeutics Inc
Publication of IL283194A publication Critical patent/IL283194A/en
Publication of IL283194B1 publication Critical patent/IL283194B1/en
Publication of IL283194B2 publication Critical patent/IL283194B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL283194A 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof IL283194B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862769383P 2018-11-19 2018-11-19
PCT/US2019/062030 WO2020106627A1 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Publications (3)

Publication Number Publication Date
IL283194A IL283194A (en) 2021-06-30
IL283194B1 IL283194B1 (en) 2024-11-01
IL283194B2 true IL283194B2 (en) 2025-03-01

Family

ID=68916562

Family Applications (1)

Application Number Title Priority Date Filing Date
IL283194A IL283194B2 (en) 2018-11-19 2019-11-18 C10-alkylene substituted 13-membered macrolides and uses thereof

Country Status (22)

Country Link
US (1) US12552825B2 (cg-RX-API-DMAC10.html)
EP (2) EP4737470A3 (cg-RX-API-DMAC10.html)
JP (2) JP7551610B2 (cg-RX-API-DMAC10.html)
KR (1) KR102929869B1 (cg-RX-API-DMAC10.html)
CN (1) CN113573779A (cg-RX-API-DMAC10.html)
AU (1) AU2019385333B2 (cg-RX-API-DMAC10.html)
BR (1) BR112021009624A2 (cg-RX-API-DMAC10.html)
CA (1) CA3120148A1 (cg-RX-API-DMAC10.html)
DK (1) DK3883647T3 (cg-RX-API-DMAC10.html)
ES (1) ES3063764T3 (cg-RX-API-DMAC10.html)
FI (1) FI3883647T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20260395T1 (cg-RX-API-DMAC10.html)
IL (1) IL283194B2 (cg-RX-API-DMAC10.html)
LT (1) LT3883647T (cg-RX-API-DMAC10.html)
MX (1) MX2021005423A (cg-RX-API-DMAC10.html)
PL (1) PL3883647T3 (cg-RX-API-DMAC10.html)
PT (1) PT3883647T (cg-RX-API-DMAC10.html)
RS (1) RS68104B1 (cg-RX-API-DMAC10.html)
SG (1) SG11202105227QA (cg-RX-API-DMAC10.html)
SI (1) SI3883647T1 (cg-RX-API-DMAC10.html)
SM (1) SMT202600094T1 (cg-RX-API-DMAC10.html)
WO (1) WO2020106627A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202313065A (zh) * 2021-05-28 2023-04-01 美商季卡尼醫療公司 用於治療遺傳疾病之化合物
WO2023250513A1 (en) * 2022-06-24 2023-12-28 Zikani Therapeutics, Inc. 13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
JP2025530776A (ja) 2022-09-01 2025-09-17 ジカニ セラピューティクス, インコーポレイテッド 13員環マクロライドを使用した家族性大腸腺腫症の処置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents
EP1985620A1 (en) * 2006-02-07 2008-10-29 Taisho Pharmaceutical Co., Ltd 10a-AZALIDE COMPOUND
WO2012001089A1 (en) * 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
NZ526120A (en) * 1999-11-09 2005-02-25 Pfizer Prod Inc 13-membered azalides and their use as antibiotic agents
JP2004516233A (ja) * 2000-04-27 2004-06-03 ファイザー・プロダクツ・インク 哺乳動物の細菌若しくは原生動物感染症を治療するか又は予防するためのアザライド抗生組成物の使用
JP4311203B2 (ja) * 2001-08-08 2009-08-12 大正製薬株式会社 11a−アザライド化合物及びその製造方法
HRP20030381B1 (en) * 2003-05-14 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. 3-DECLADINOZYL 9a-N-CARBAMOYL AND 9a-N-THIOCARBAMOYL DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICYNE A
WO2004108744A2 (en) * 2003-05-19 2004-12-16 Prasad K Deshpande Azalides and azaketolides having antimicrobial activity
WO2005042554A1 (en) * 2003-10-30 2005-05-12 Rib-X Pharmaceuticals, Inc. Bifunctional macrolide heterocyclic compounds and methods of making and using the same
RU2008106915A (ru) * 2005-07-26 2009-09-10 Меркле Гмбх (De) Макролидные конъюгаты пирролиновых и индолизиновых соединений
CN102993250B (zh) * 2011-07-06 2016-02-10 洛阳惠中兽药有限公司 C-3取代的-9-脱氧-9a-氮杂-9a-高红霉素a衍生物
EP4095146A1 (en) 2013-04-04 2022-11-30 President And Fellows Of Harvard College Macrolides and methods of their preparation and use
JP2017531663A (ja) 2014-10-08 2017-10-26 プレジデント アンド フェローズ オブ ハーバード カレッジ 14員ケトライドならびにそれらの調製および使用の方法
WO2016154591A1 (en) 2015-03-25 2016-09-29 President And Fellows Of Harvard College Macrolides with modified desosamine sugars and uses thereof
EP3277701A4 (en) 2015-03-25 2019-03-06 President and Fellows of Harvard College SYNTHESIS OF DESOSAMINES
CA3000709A1 (en) * 2015-10-01 2017-04-06 Memorial Sloan-Kettering Cancer Center Inhibitors of menaquinone biosynthesis
US11673910B2 (en) * 2017-04-28 2023-06-13 Zikani Therapeutics, Inc. Macrolides with modified desosamine sugars and uses thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000031097A1 (en) * 1998-11-20 2000-06-02 Pfizer Products Inc. 13-membered azalides and their use as antibiotic agents
EP1985620A1 (en) * 2006-02-07 2008-10-29 Taisho Pharmaceutical Co., Ltd 10a-AZALIDE COMPOUND
WO2012001089A1 (en) * 2010-07-01 2012-01-05 Novartis Ag Antibiotic compositions

Also Published As

Publication number Publication date
IL283194B1 (en) 2024-11-01
EP3883647B1 (en) 2026-02-11
SMT202600094T1 (it) 2026-03-09
RS68104B1 (sr) 2026-06-30
SI3883647T1 (sl) 2026-04-30
MX2021005423A (es) 2021-09-08
IL283194A (en) 2021-06-30
JP7551610B2 (ja) 2024-09-17
FI3883647T3 (fi) 2026-03-25
JP2025000636A (ja) 2025-01-07
EP4737470A3 (en) 2026-07-22
PT3883647T (pt) 2026-02-26
DK3883647T3 (da) 2026-03-23
SG11202105227QA (en) 2021-06-29
PL3883647T3 (pl) 2026-06-01
US12552825B2 (en) 2026-02-17
EP4737470A2 (en) 2026-05-06
JP2022507776A (ja) 2022-01-18
AU2019385333B2 (en) 2025-04-17
LT3883647T (lt) 2026-03-25
HRP20260395T1 (hr) 2026-05-08
EP3883647A1 (en) 2021-09-29
KR20210133950A (ko) 2021-11-08
CA3120148A1 (en) 2020-05-28
US20230093692A1 (en) 2023-03-23
WO2020106627A1 (en) 2020-05-28
ES3063764T3 (en) 2026-04-20
BR112021009624A2 (pt) 2021-08-10
KR102929869B1 (ko) 2026-02-23
AU2019385333A1 (en) 2021-07-01
CN113573779A (zh) 2021-10-29

Similar Documents

Publication Publication Date Title
EP2988597B1 (en) Macrolides and methods of their preparation and use
EP3664799B1 (en) Lincosamide antibiotics and uses thereof
US11535643B2 (en) Macrolides with modified desosamine sugars and uses thereof
US20260035402A1 (en) C10-alkylene substituted 13-membered macrolides and uses thereof
AU2023229518A1 (en) C10-Cyclic Substituted 13-Membered Macrolides and Uses Thereof
JP2025000636A (ja) C10-アルキレン置換された13員マクロライド及びそれらの使用
WO2016057798A1 (en) 14-membered ketolides and methods of their preparation and use
CA3249734A1 (en) LINCOSAMIDES AND THEIR USES
US20230242565A1 (en) Macrolides with Modified Desosamine Sugars and Uses Thereof
EA052403B1 (ru) C10-алкилен-замещенные 13-членные макролиды и их применение
BR122025025362A2 (pt) Macrolídeos com 13 membros substituídos por c10-alquileno e usos dos mesmos
HK40063711A (en) C11-cyclic substituted 13-membered macrolides and uses thereof
HK40063248A (en) C10-alkylene substituted 13-membered macrolides and uses thereof